Back to MORGAN STANLEY MORGAN STANLEY

BBNXBBNX
6 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in BETA BIONICS INC

MORGAN STANLEY holds 4.3M shares of BBNX (BETA BIONICS INC), worth $66.9M as of 2026-Q2. The position was increased (+0.9% shares). BBNX represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$66.9M

Current Shares

4.3M

Total Value Change

+$49.7M

Total Shares Change

+2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.3M
+0.9%
$66.9M0.0%$15.67
30
2026-Q1
Increased
4.2M
+22.2%
$42.4M0.0%$11.57
35
2025-Q4
Decreased
3.5M
-8.0%
$105.4M0.0%$31.97
0
2025-Q3
Increased
3.8M
+27.5%
$74.7M0.0%$19.85
37
2025-Q2
Increased
2.9M
+110.4%
$42.9M0.0%$15.07
47
2025-Q1
New
1.4M
-
$17.2M0.0%$11.71
39

Other major holders of BBNX: FARALLON CAPITAL MANAGEMENT, L.L.C., BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used